Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Fig. 2

a Biochemical recurrence free survival (≤0.2 ng/ml) in all patients (PSA persistence vs. PSA recurrence) at last follow-up. b Biochemical recurrence free survival (≤0.2 ng/ml) in all patients without antiandrogen therapy (PSA persistence vs. PSA recurrence) at last follow-up. c Biochemical recurrence free survival (≤0.2 ng/ml) in all PET-positive patients (PSA persistence vs. PSA recurrence) at last follow-up. d Biochemical recurrence free survival (≤0.2 ng/ml) in all PET-positive patients without antiandrogen therapy (PSA persistence vs. PSA recurrence) at last follow-up

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us